독서리서치레이더투자 프레임워크
로그인 / 회원가입
← 읽기로 돌아가기
뉴스주제 · AI药物研发实验猴短缺간단한 요점1 분 소요DisconfirmAI 편집부

Palantir Cofounder Joe Lonsdale Reportedly Backs Plan for 30,000-Monkey Farm in US to Ease AI Drug Discovery Bottleneck

AI-accelerated drug discovery has driven up demand and prices for lab monkeys. Palantir cofounder Joe Lonsdale is reportedly backing a 20-year US breeding plan, though biological cycles and welfare concerns pose challenges.

2026-11-03 09:15 GMT+8

According to TechRadar, Palantir cofounder Joe Lonsdale is reportedly supporting Safer Human Medicine, a startup planning to establish a large-scale macaque breeding facility in the United States that would eventually house 30,000 monkeys. The initiative aims to address the supply pressure on animal test subjects caused by AI-accelerated drug discovery.

AI technology enables researchers to generate potential drug candidates more rapidly, increasing the need for toxicity, safety, and biological effect testing. Macaques are frequently selected due to their biological similarities to humans. However, US laboratories face severe shortages after China banned exports of lab monkeys in 2020 (previously accounting for about 60% of US imports) and alternative sources like Cambodia faced allegations of wild-caught animals being misrepresented as captive-bred. Reported prices for macaques have surged from approximately $3,000 in 2019 to over $20,000 today, a 700% increase.

Safer Human Medicine plans to gradually expand its population over approximately 20 years, starting with an initial stock of 500 to 1,000 macaques obtained from Asian facilities. However, female macaques typically reach reproductive maturity around four years of age and produce one offspring annually, meaning domestic capacity will take a long time to scale. Additionally, the plan has attracted criticism from animal welfare advocates, potentially leading to legal challenges that could further delay the project.

출처

로그인 / 회원가입
독서리서치레이더투자 프레임워크
  • techradar.comTechRadar↗
주제

AI药物研发实验猴短缺

【AI药物研发实验猴短缺】已成为全球生物医药行业的结构性瓶颈。Palantir联合创始人Joe Lonsdale据报支持初创公司Safer Human Medicine在美国建立大型养殖场,计划20年内繁育3万只食蟹猴以缓解供应危机。此前中…

8 단계1 건업데이트됨 2026-11-03 15:06

현재까지의 과정

  1. 2020-01-01中国禁止实验猴出口,切断美国主要供应源,迫使实验室转向柬埔寨等地采购。techradar.com ↗
  2. 2022-01-01美国司法部调查揭露柬埔寨将野生捕获猴子伪报为人工养殖出口,进一步扰乱供应链。leonliao.substack.com ↗
  3. 2023-12-01佐治亚州Bainbridge官员初步同意为Safer Human Medicine提供土地和税收优惠以建设养殖场。aol.com ↗

아직 해결되지 않은 문제

  • Safer Human Medicine与佐治亚州政府的合同纠纷最终裁决结果如何?
  • FDA是否会因AI技术进步而调整非人灵长类动物测试的强制性要求?
  • 中国能否通过恢复从柬埔寨等国的合法进口来填补2026-2028年的预期缺口?
전체 주제 읽기 →
리서치 계속하기 →